RANGO Registry

International, multicenter, prospective and observational registry. Evaluation of safety and efficacy of angiolite drug eluting stent in non-selected patients from the clinical daily practice.

Description

Device: angiolite

Number of patients: 654

Follow up: 6, 12 and 24- month

Type of lesion: Non-selected, real world population

Primary endpoint

Primary endpoint

  • Target Lesion Failure (TLF) at 6, 12 and 24 months

Secondary endpoints

Secondary endpoints

  • Cardiac death at 6, 12 and 24 months
  • Stent thrombosis at 6, 12 and 24 months
  • Myocardial infarction 6, 12 and 24 months
  • Target Lesion Revascularization (TLR) 6, 12 and 24 months

Main investigator

Dr A. Pérez de Prado, Hospital and  University of León (León, SPA)

All Clinical Trials

All Clinicals Trials
ANGIOLITE Trial
ANCHOR Trial